ClinicalTrials.Veeva

Menu
A

Activian Clinical Research | Kingwood, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Orforglipron
LY3502970
Eloralintide
PF-08653944
Tirzepatide
PF-08653945
LY3298176
LY3841136
Bimagrumab

Parent organization

This site is a part of Activian Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 9 total trials

A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes

The purpose of this Master Protocol is to support two studies to see how well and how safely orforglipron works compared to placebo in participants w...

Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Orforglipron
Locations recently updated

The main purpose of this study is to evaluate the efficacy and safety of eloralintide compared with placebo in participants with persistent obesity o...

Enrolling
Overweight
Obesity
Drug: Placebo
Drug: Eloralintide

The main purpose of this study is to see how orforglipron, compared with placebo, helps reduce body weight in participants with obesity or with overw...

Active, not recruiting
Overweight
Obesity
Drug: Orforglipron
Drug: Placebo

The GZPT master protocol will support two independent studies, J2A-MC-GZT1 and J2A-MC-GZT2. Each study will see how well and safely orforglipron work...

Enrolling
Osteoarthritis
Drug: Orforglipron
Drug: Placebo

The main purpose of this study is to see how orforglipron, compared with placebo, helps improve glycemic control in participants with obesity or with...

Active, not recruiting
Overweight
Obesity
Drug: Orforglipron
Drug: Placebo

This study is being done to learn about the safety and effects of the study drugs, PF-08653945 and PF-08653944, when given alone or together for weig...

Enrolling
Overweight and/or Obesity
Nutrition Disorders
Drug: PF-08653944
Drug: PF-08653945

Trial sponsors

Lilly logo
H
Moderna logo
Pfizer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems